SURGICAL
Automated and personalized glioblastoma tumor organoid drug screening platform exposes sensitivity to proteasome and HDAC inhibitors.
Jungwirth G, Paul A, Wöllner A, Warta R, Cao J, Fermi V, Jassowicz L, Dao Trong P, von Deimling A, Debus J, Krieg S, Unterberg A, Abdollahi A, Herold-Mende C
- Year
- 2026
- Journal
- NPJ precision oncology
Keywords
glioblastomaorganoiddrug screeningproteasome inhibitorsHDAC inhibitors
Related papers
SURGICAL
📊 2,712 cites
Campbell-Walsh urology
Alan J. Wein editor-in-chief
2012
SURGICAL
📊 2,062 cites
Principles of Robot Motion: Theory, Algorithms, and Implementations
Howie Choset, Jean‐Claude Latombe
2005
SURGICAL
Open access📊 1,859 cites
Minimally Invasive versus Abdominal Radical Hysterectomy for Cervical Cancer
Pedro T. Ramírez, Michael Frumovitz, René Pareja +16 more
2018
SURGICAL
📊 1,839 cites
Guideline for Management of the Clinical T1 Renal Mass
Steven C. Campbell, Andrew C. Novick, Arie S. Belldegrun +9 more
2009